(Q46031092)

18 December 2017

title

Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP). (English)

1 reference

18 December 2017

author name string

Lazaros Konstantinidis

1

1 reference

18 December 2017

Evangelia Mameletzi

2

1 reference

18 December 2017

Irmela Mantel

3

1 reference

18 December 2017

Jean-Antoine Pournaras

4

1 reference

18 December 2017

Leonidas Zografos

5

1 reference

18 December 2017

Aude Ambresin

6

1 reference

18 December 2017

publication date

29 April 2009

1 reference

18 December 2017

Graefe's Archive for Clinical and Experimental Ophthalmology

published in

1 reference

18 December 2017

volume

247

1 reference

18 December 2017

issue

9

1 reference

18 December 2017

page(s)

1165-1171

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s00417-009-1089-3

exact match

0 references

cites work

Proper method for calculating average visual acuity.

1 reference

12 December 2020

Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.

1 reference

12 December 2020

Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation.

1 reference

12 December 2020

Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation

1 reference

12 December 2020

Retinal angiomatous proliferation reactivation 6 months after high-dose intravitreal acetonide triamcinolone and photodynamic therapy.

1 reference

12 December 2020

Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation

1 reference

12 December 2020

Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation

1 reference

12 December 2020

Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation

1 reference

12 December 2020

Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone.

1 reference

12 December 2020

Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study

1 reference

12 December 2020

Recurrence after surgical ablation for retinal angiomatous proliferation.

1 reference

12 December 2020

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

1 reference

12 December 2020

Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation

1 reference

12 December 2020

Photodynamic therapy with verteporfin for retinal angiomatous proliferation

1 reference

12 December 2020

Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.

1 reference

12 December 2020

Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation

1 reference

12 December 2020

Retinal angiomatous proliferation treated with a combination of intravitreal triamcinolone acetonide and photodynamic therapy with verteporfin

1 reference

12 December 2020

Combined surgical ablation and intravitreal triamcinolone acetonide for retinal angiomatous proliferation.

1 reference

12 December 2020

Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration.

1 reference

12 December 2020

Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1

1 reference

12 December 2020

Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation.

1 reference

12 December 2020

[Periocular sub-tenon triamcinolone acetonide injections for the treatment of retinal angiomatous proliferation (RAP) and occult choroidal neovascularisation]

1 reference

12 December 2020

An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration

1 reference

12 December 2020

Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation

1 reference

12 December 2020

Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization

1 reference

12 December 2020

Ranibizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Review of retinal angiomatous proliferation or type 3 neovascularization

1 reference

12 December 2020

Retinal angiomatous proliferation in age-related macular degeneration

1 reference

12 December 2020

Clinicopathological findings of retinal angiomatous proliferation

1 reference

12 December 2020

Retinal angiomatous proliferation complicated by pigment epithelial tear following intravitreal bevacizumab treatment

1 reference

12 December 2020

Combining surgical ablation of retinal inflow and outflow vessels with photodynamic therapy for retinal angiomatous proliferation

1 reference

12 December 2020

Surgical Ablation of Retinal Angiomatous Proliferation

1 reference

12 December 2020

Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation

1 reference

12 December 2020

Surgical excision of neovascularization in retinal angiomatous proliferation

1 reference

12 December 2020

Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes

1 reference

12 December 2020

Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study

1 reference

12 December 2020

10.1007/S00417-009-1089-3

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

19404661

1 reference

18 December 2017